Username/Email ID: Password:
Welcome To InvestmentGuruIndia 


Brokers View
Hold CRISIL Limited - PPFAS

 *  Good operating performance for the quarter & year ended December 2011 

*  IREVNA & Pipal Research report sustained growth  

*  Rating business was supported by BLR & SME ratings as...

Buy Dr. Reddy’s Laboratories Ltd. For Target 1864 - Firstcall Research

Investment Highlights

Q3 FY12 Results Update

Dr. Reddy’s Lab. has reported consolidated net profit of Rs 5129.60 million for the quarter ended on December 31, 2011 as against Rs. 2731.40 mil...

Buy Allcargo Global Logistics For Target 190 - Kotak Securities

Slightly subdued operational performance

Allcargo Logistics (AGLL) reported a consolidated adjusted PAT of Rs 508 mn vs. our estimate of Rs 560 mn and consensus estimate of Rs 600 mn in 4Q CY11, up ~20% YoY but falling 10%...

Reduce Areva T&D India Ltd For Target 158 - Kotak Securities

 *  The company has presented separate numbers for the continuing part of the business (Transmission) and discontinuing operations  distribution).

Hence yoy comparison is not relavant

 *  The T&D indust...

Accumulate Thomas Cook (India) Ltd For Target 64.2 GEPL Capital

Q4CY11 – Results better than estimates; expect growth to continue

• Thomas Cook India Ltd. (TCIL) witnessed a 30.8% Y-o-Y growth in revenues to `873 mn driven by a 37.2% Y-o-Y growth in travel related services a...

Hold Astral Poly Technik Ltd. For Target 226 - Nirmal Bang

  Sales ahead of expectations but margins decline

 * Revenues grew 63% YoY at Rs.160.5 crores. This was on the back of continues demand for its products and a promotional scheme offered by the company during the...

Buy Dhanuka Argitech Ltd For Target 116 - Nirmal Bang

Results below expectations

Dhanuka Agritech reported results lower than expectations due to bad North East Monsoon which impacted the whole agrochemicals’ industry.
The reported sales of Rs 109.8 cr has declin...

Buy Vivimed Labs Ltd. For Target 468 - Ventura

We initiate coverage on Vivimed Labs Ltd as a BUY with a Price Objective of ` 468 (target 7.5x FY14 EPS). At CMP of ` 343, the stock is trading at 6.0x and 5.5x its estimated earnings for FY13 & FY14 representing a potential upside of ~36% ove...

Buy Cipla Limited - Ventura

Key Takeaways

Net revenues were up 13.2% to Rs 1758 crore while profits grew 16% to Rs 269.9 crore. However margins experienced a 230 bps drop qoq despite the benefits of a depreciating Re and growing vol...

Buy Dr Reddy Laboratories Limited For Target 1900 - Ventura

Key Takeaways

Dr Reddy Laboratories Limited (Dr Reddy) reported a 47% growth in Net Sales to Rs. 2,769 crore driven by higher than expected sales (~99 mn) generated through Zyprexa (Olanzapine) FTF exclusivity. Aided by fa...

Hold State Bank of India Ltd. - Ventura

Key Takeaways

  * SBI’s advances grew ahead of expectations at 18% (tracking the system growth of 18%) to 8,69,393 driven largely by a 9% qoq expansion of its large corporate book, 7.2% qoq growth in the home lo...

Buy Pfizer Ltd For Target 1329 - Firstcall Research

Investment Highlights

Q3 FY12 Results Update

Pfizer has posted a net profit of Rs 482.80 million for the quarter ended Dec. 31, 2011 as compared to Rs 435.80 million for the quarter ended Dec. 31,...

Hold Eicher Motors Ltd - Nirmal Bang

Results good; Outlook remains positive

Eicher Motor results are good. Although parent company (12% of consolidated sales) saw some decline on account of lower sales on Bullet motorcycle but subsidiary continue to perform w...

Buy Nitin Fire Protection Industries Ltd. For Target 50 - SKP Securities

Company Profile

Nitin Fire Protection Industries Ltd (NFPIL) is an end to end solution provider for fire protection, safety and security systems with the capabilities in designing, engineering, commissioning and maintenanc...

Buy Aurobindo Pharma For Target 138 - Karvy Stock Broking

Improved quarterly performance – Better Visibility

Revenues for the quarter grew by 7.7% to Rs 12.8 bn due to better traction in formulations space, primarily in ARV and EU+ RoW space. US revenues continues to grow q...

Buy Essel Propack Ltd. For Target 46 - Nirmal Bang

Quarterly Analysis

Essel Propack Global operations reported a jump in net sales YoY by 13.7% and up by 4.7% QoQ to Rs. 414.04 crs backed by strong growth registered in all four regions comprising: AMESA (10.5% YoY), AMERIC...

Buy Cox & Kings Ltd. For Target 243 - GEPL Capital

Q3FY12 – Standalone results surprise positively leading to lesser than  estimated losses in Q3FY12

• Cox & Kings Ltd. (C&K) witnessed a 162.8% Y-o-Y growth to `2.85 led by the acqui...

Buy Muthoot Finance Limited For Target 197 - Hedge Equities

Business Summary

Muthoot Finance Limited (MFL) is India’s largest gold loan financing company (in terms of loan portfolio with an AUM of Rs.22694 crores) and a market share of 19.5% of the total gold loan market in I...

Update Shriram Transport Finance Company Ltd. - GEPL Capital

Q3FY12 – Lower margins impacted profitability

• The company reported PAT growth of 0.4% Y-o-Y in Q3FY12 mainly due to lower margins.

• Net Interest Income (NII) has declined by 0.7% Y-o-Y basis in Q...

Buy Power Grid Corporation of India Ltd. - Ventura

Key Takeaways

Power Grid Corporation of India Ltd. (PGCIL) posted a 20.2% increase in revenues on yearly basis to Rs. 2,466 crore on the back of 18.4% revenue growth in transmission segment and 82% increase in revenues fro...


First Previous
1  2  3  4  5  6  7  8  9  10 
Next Last
Page 1 of 85


Contact Us| About Us| Disclaimer | Privacy & policy| Terms & Condition| Our Products & Services| Careers| Feedback| Enquiry
Copyright © investmentguruindia.com | Powered By BD Info Media Pvt Ltd & Navigators Technology. Content Source: Reuters, Dion Global Solutions Ltd
Keyword: share market online, india share market trading, bombay stock market, crash stock, stock market investing, stock market india, stock market online, investment india, stock trading tips, stock market trading tips, share trading tips, MoneyControl
Disclaimer: ADVICE RECEIVED VIA THIS WEB SITE SHOULD NOT BE RELIED UPON FOR PERSONAL, MEDICAL, LEGAL OR FINANCIAL DECISIONS AND YOU SHOULD CONSULT AN APPROPRIATE PROFESSIONAL FOR SPECIFIC ADVICE TAILORED TO YOUR SITUATION. INVESTMENTGURUINDIA.COM OR BD INFO MEDIA PVT LTD MAKES NO REPRESENTATIONS ABOUT THE SUITABILITY, RELIABILITY, TIMELINESS, AND ACCURACY OF THE INFORMATION, SOFTWARE, PRODUCTS, SERVICES AND RELATED GRAPHICS CONTAINED ON THIS WEB SITE FOR ANY PURPOSE. ALL SUCH INFORMATION, SOFTWARE, PRODUCTS, SERVICES AND RELATED GRAPHICS ARE PROVIDED "AS IS" WITHOUT WARRANTY OF ANY KIND. INVESTMENTGURUINDIA.COM OR BD INFO MEDIA PVT LTD HEREBY DISCLAIMS ALL WARRANTIES AND CONDITIONS WITH REGARD TO THIS INFORMATION, SOFTWARE, PRODUCTS, SERVICES AND RELATED GRAPHICS, INCLUDING ALL IMPLIED WARRANTIES AND CONDITIONS OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, TITLE AND NON-INFRINGEMENT. IN NO EVENT SHALL INVESTMENTGURUINDIA.COM OR BD INFO MEDIA PVT LTD BE LIABLE FOR ANY DIRECT, INDIRECT, PUNITIVE, INCIDENTAL, SPECIAL, CONSEQUENTIAL DAMAGES OR ANY DAMAGES WHATSOEVER INCLUDING, WITHOUT LIMITATION, DAMAGES FOR LOSS OF USE, DATA OR PROFITS, ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE USE OR PERFORMANCE OF THIS WEB SITE, WITH THE DELAY OR INABILITY TO USE THIS WEB SITE, THE PROVISION OF OR FAILURE TO PROVIDE SERVICES, OR FOR ANY INFORMATION, SOFTWARE, PRODUCTS, SERVICES AND RELATED GRAPHICS OBTAINED THROUGH THIS WEB SITE, OR OTHERWISE ARISING OUT OF THE USE OF THIS WEB SITE, WHETHER BASED ON CONTRACT, TORT, STRICT LIABILITY OR OTHERWISE, EVEN IF INVESTMENTGURUINDIA.COM OR BD INFO MEDIA PVT LTD HAS BEEN ADVISED OF THE POSSIBILITY OF DAMAGES. BECAUSE SOME STATES/JURISDICTIONS DO NOT ALLOW THE EXCLUSION OR LIMITATION OF LIABILITY FOR CONSEQUENTIAL OR INCIDENTAL DAMAGES, THE ABOVE LIMITATION MAY NOT APPLY TO YOU. IF YOU ARE DISSATISFIED WITH ANY PORTION OF THIS WEB SITE, OR WITH ANY OF THESE TERMS OF USE, YOUR SOLE AND EXCLUSIVE REMEDY IS TO DISCONTINUE USING THIS WEB SITE. MUTUAL FUND INVESTMENTS IS SUBJECT TO MARKET RISK. PLEASE READ THE COMPLETE OFFER DOCUMENT, PRODUCT BROCHURE BEFORE MAKING INVESTMENTS. BEFORE INVESTING IN INSURANCE PLEASE READ THE COMPLETE PRODUCT DETAILS AND TAKE REGISTERED EXPERT ADVICE TO UNDERSTAND THE FINER POINTS & DETAILS OF THE PRODUCTS. Read Complete Disclaimer